玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近8季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益率 QoQ YoY稅後淨利率 QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
26Q1 (8)240.00.0-0.392.5-14.71-0.507.41-51.52-0.3980.1-14.710.4-28.57-39.3936.4019.6217.38-28.32-19.95-176.02-23.67-32.53-122.05-0.1115.38-57.14-0.10.0-25.0-23.67-25.3-122.05-23.67-32.53-122.05-0.6511.253.71
25Q4 (7)240.00.0-0.4020.0-350.0-0.540.028.0-1.96-25.64-14.620.5627.27-1.7530.43-12.6838.51-23.6116.8739.21-17.8633.8-324.23-0.13-8.3340.91-0.116.67-350.0-18.8929.99-3919.15-17.8633.8-324.2321.5325.760.00
25Q3 (6)240.00.0-0.5031.5112.28-0.540.00.0-1.56-47.1716.580.4415.79-26.6734.85-6.691.25-28.4023.26-30.1-26.9845.96-14.42-0.1214.297.69-0.1233.3314.29-26.9845.77-14.42-26.9845.96-14.42-13.32-41.60-31.82
25Q2 (5)240.00.0-0.73-114.71-43.14-0.54-63.640.0-1.06-211.7618.460.38-42.42-29.6337.3520.4515.46-37.01-260.72-30.36-49.93-368.39-89.85-0.14-100.06.67-0.18-125.0-50.0-49.75-366.7-89.52-49.93-368.39-89.85--0.00
25Q1 (4)240.00.0-0.34-312.50.0-0.3356.00.0-0.3480.120.00.6615.790.031.0141.150.0-10.2673.580.0-10.66-153.210.0-0.0768.180.0-0.08-300.00.0-10.66-2168.090.0-10.66-153.210.0--0.00
24Q4 (3)240.00.00.16128.070.0-0.75-38.890.0-1.718.560.00.57-5.00.021.97-36.170.0-38.84-77.920.0-4.2182.150.0-0.22-69.230.00.04128.570.0-0.4798.010.0-4.2182.150.0--0.00
24Q3 (2)240.00.0-0.57-11.760.0-0.540.00.0-1.87-43.850.00.611.110.034.426.40.0-21.8323.110.0-23.5810.340.0-0.1313.330.0-0.14-16.670.0-23.5810.170.0-23.5810.340.0--0.00
24Q2 (1)240.00.0-0.510.00.0-0.540.00.0-1.300.00.00.540.00.032.350.00.0-28.390.00.0-26.300.00.0-0.150.00.0-0.120.00.0-26.250.00.0-26.300.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2026/40.08-35.2-38.530.49-39.290.33N/A-
2026/30.1310.05-65.590.4-39.450.41.09因動物醫療儀器較去年減少所致。
2026/20.12-22.28-14.520.27-4.560.510.86-
2026/10.15-35.994.950.154.950.540.82-
2025/120.2464.0697.372.04-15.010.540.84本公司動物醫療儀器出貨量較去年同期增加。
2025/110.15-5.2-1.071.8-20.960.490.93-
2025/100.15-17.92-49.481.66-22.330.490.92-
2025/90.1924.3121.471.5-17.830.461.2-
2025/80.1524.44-40.131.32-21.440.361.54-
2025/70.1242.14-37.281.17-18.140.371.51-
2025/60.09-46.65-55.071.05-15.150.381.41本公司動物醫療儀器出貨量較去年同期減少,收入下降
2025/50.1615.73-12.450.96-7.920.680.8-
2025/40.14-63.73-19.360.8-6.960.660.82-
2025/30.38173.4444.490.66-3.90.660.72-
2025/20.14-4.57-52.890.28-43.350.451.06喪失睿邑公司控制力,不將該公司營收併入集團營收。
2025/10.15-12.64-29.80.15-29.80.471.02-
2024/120.175.24-46.133.0812.270.630.75-
2024/110.16-47.88-22.312.9219.680.720.65-
2024/100.318.11-21.042.7623.510.890.53-
2024/90.26-20.65-34.012.4632.780.831.01-
2024/80.3230.5145.832.250.620.880.95主係保健食品銷量增加
2024/70.25-19.3641.541.8751.480.771.09主係保健食品銷量增加
2024/60.3145.27183.651.6353.120.811.05主係保健食品銷量增加
2024/50.21-26.1616.381.3238.250.821.04-
2024/40.29-9.350.981.1143.410.90.95主係保健食品銷量增加
2024/30.327.3827.920.8240.940.82N/A-
2024/20.2942.270.860.550.590.81N/A主係保健食品銷量增加
2024/10.21-32.9728.860.2128.860.72N/A-
2023/120.3151.847.642.817.40.97N/A-
2023/110.2-54.99-4.272.513.91.05N/A-
2023/100.4516.15199.312.34.691.06N/A本公司新增保健食品業務,整體收入較同期上升
2023/90.3975.3654.311.85-9.670.79N/A本公司新增保健食品業務,整體收入較同期上升
2023/80.2226.68-2.811.46-18.680.51N/A-
2023/70.1861.58-40.541.24-21.00.47N/A-
2023/60.11-40.38-64.891.06-16.460.48N/A本公司機台出貨量較去年同期減少,收入下降
2023/50.18-4.21-30.030.95-0.890.62N/A-
2023/40.19-23.1535.050.779.910.61N/A-
2023/30.2543.4316.870.583.60.58N/A-
2023/20.177.2411.710.33-4.440.54N/A-
2023/10.16-23.2-17.280.16-17.280.58N/A-
2022/120.21-1.5776.422.62114.230.57N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/110.2140.7280.022.41118.30.62N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/100.15-40.1191.772.2122.890.63N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/90.2510.44108.912.05125.590.78N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/80.23-22.5209.851.79128.160.83N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/70.3-4.58277.551.57119.690.86N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/60.3118.879.01.27100.260.71N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/50.2684.89214.680.96108.210.61N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/40.14-33.596.930.784.980.51N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/30.2137.09171.030.5682.210.56N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/20.15-20.5847.610.3551.990.47N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/10.1963.7855.650.1955.650.43N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2021/120.120.43-19.61.2220.510.32N/A-
2021/110.1249.9174.691.127.340.32N/A本公司新增之防疫產品銷量穩定,整體收入較同期上升
2021/100.08-34.7523.650.9919.650.27N/A-
2021/90.1263.8131.190.9119.310.27N/A本公司新增之防疫產品銷量穩定,整體收入較同期上升
2021/80.07-5.56-40.730.7911.050.32N/A-
2021/70.08-54.76-25.180.7122.110.33N/A-
2021/60.17108.84169.010.6332.410.0N/A係受新冠疫情影響,本公司防疫產品銷量增加。
2021/50.0815.7-16.750.4611.280.0N/A-
成長能力-近5年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益率 YoY稅後淨利率 YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2025 (5)240.0-1.960-1.8802.04-15.032.865.25-22.800-23.480-0.470-0.480-0.470
2024 (4)244.35-1.710-2.6202.4-5.8831.22122.84-28.300-20.180-0.680-0.460-0.410
2023 (3)2327.784.490-3.8302.550.3914.01-7.16-36.51040.430-0.9301.0301.040
2022 (2)18-75.34-3.770-4.4602.54108.215.090-43.440-27.180-1.110-0.70-0.670
2021 (1)7317.74-1.300-4.2901.2220.79-6.480-84.420-77.970-1.030-0.950-0.950

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。